{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T23:55:45Z","timestamp":1792540545216,"version":"4.5.0"},"reference-count":47,"publisher":"American Society of Clinical Oncology (ASCO)","issue":"2","content-domain":{"domain":["ascopubs.org"],"crossmark-restriction":true},"short-container-title":["JCO"],"published-print":{"date-parts":[[2024,1,10]]},"abstract":"<jats:sec>\n                    <jats:title>PURPOSE<\/jats:title>\n                    <jats:p>Approximately 30%-40% of patients with relapsed\/refractory (R\/R) large B-cell lymphoma (LBCL) infused with CD19-targeted chimeric antigen receptor (CAR) T cells achieve durable responses. Consensus guidelines suggest avoiding bendamustine before apheresis, but specific data in this setting are lacking. We report distinct outcomes after CAR T-cell therapy according to previous bendamustine exposure.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS<\/jats:title>\n                    <jats:p>The study included CAR T-cell recipients from seven European sites. Safety, efficacy, and CAR T-cell expansion kinetics were analyzed according to preapheresis bendamustine exposure. Additional studies on the impact of the washout period and bendamustine dose were performed. Inverse probability treatment weighting (IPTW) and propensity score matching (PSM) analyses were carried out for all efficacy comparisons between bendamustine-exposed and bendamustine-na\u00efve patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>\n                      The study included 439 patients with R\/R LBCL infused with CD19-targeted commercial CAR T cells, of whom 80 had received bendamustine before apheresis. Exposed patients had significantly lower CD3\n                      <jats:sup>+<\/jats:sup>\n                      cells and platelets at apheresis. These patients had a lower overall response rate (ORR, 53% v 72%; P &lt; .01), a shorter progression-free survival (PFS, 3.1 v 6.2 months; P = .04), and overall survival (OS, 10.3 v 23.5 months; P = .01) in comparison with the bendamustine-na\u00efve group. Following adjustment methods for baseline variables, these differences were mitigated. Focusing on the impact of bendamustine washout before apheresis, those with recent (&lt;9 months) exposure (N = 42) displayed a lower ORR (40% v 72%; P &lt; .01), shorter PFS (1.3 v 6.2 months; P &lt; .01), and OS (4.6 v 23.5 months; P &lt; .01) in comparison with bendamustine-na\u00efve patients. These differences remained significant after IPTW and PSM analysis. Conversely, the cumulative dose of bendamustine before apheresis did not affect CAR-T efficacy outcomes.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION<\/jats:title>\n                    <jats:p>Recent bendamustine exposure before apheresis was associated with negative treatment outcomes after CD19-targeted CAR T-cell therapy and should be therefore avoided in CAR T-cell candidates.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1200\/jco.23.01097","type":"journal-article","created":{"date-parts":[[2023,10,24]],"date-time":"2023-10-24T16:00:16Z","timestamp":1698163216000},"page":"205-217","update-policy":"https:\/\/doi.org\/10.1200\/crossmark","source":"Crossref","is-referenced-by-count":127,"title":["Recent Bendamustine Treatment Before Apheresis Has a Negative Impact on Outcomes in Patients With Large B-Cell Lymphoma Receiving Chimeric Antigen Receptor T-Cell Therapy"],"prefix":"10.1200","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0805-9288","authenticated-orcid":false,"given":"Gloria","family":"Iacoboni","sequence":"first","affiliation":[{"name":"Department of Hematology, University Hospital Vall d'Hebron, Barcelona, Spain"},{"name":"Experimental Hematology, Vall d\u2019Hebron Institute of Oncology (VHIO), Barcelona, Spain"},{"name":"Department of Medicine, Universitat Aut\u00f2noma de Barcelona, Bellaterra, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6925-4605","authenticated-orcid":false,"given":"V\u00edctor","family":"Navarro","sequence":"additional","affiliation":[{"name":"Oncology Data Science (ODySey) Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana \u00c1frica","family":"Mart\u00edn-L\u00f3pez","sequence":"additional","affiliation":[{"name":"Hematology Department, Hospital Cl\u00ednico Universitario de Salamanca, IBSAL, CIBERONC, Salamanca, Spain"},{"name":"Centro de Investigaci\u00f3n del C\u00e1ncer-IBMCC, Salamanca, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3905-0251","authenticated-orcid":false,"given":"Kai","family":"Rejeski","sequence":"additional","affiliation":[{"name":"Department of Medicine III, University Hospital, LMU Munich, Munich, Germany"},{"name":"Laboratory for Translational Cancer Immunology, Gene Center of the LMU Munich, Munich, Germany"},{"name":"German Cancer Consortium (DKTK) and Bavarian Center for Cancer Research (BZKF), partner site Munich, Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3855-7774","authenticated-orcid":false,"given":"Mi","family":"Kwon","sequence":"additional","affiliation":[{"name":"Department of Hematology, Hospital General Universitario Gregorio Mara\u00f1\u00f3n, Madrid, Spain"},{"name":"Gregorio Mara\u00f1\u00f3n Health Research Institute (IiSGM), Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3284-8308","authenticated-orcid":false,"given":"Katarzyna Aleksandra","family":"Jalowiec","sequence":"additional","affiliation":[{"name":"Hematology Department, University College London Cancer Institute, London, United Kingdom"},{"name":"Department of Hematology and Central Hematology Laboratory, University Hospital of Bern, Bern, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Amat","sequence":"additional","affiliation":[{"name":"Haematology Department, Hospital Cl\u00ednico Universitario, Valencia, Spain"},{"name":"INCLIVA Research Institute, Valencia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Luis","family":"Reguera-Ortega","sequence":"additional","affiliation":[{"name":"Hematology Department, Hospital Virgen del Roc\u00edo, Instituto de Biomedicina de Sevilla (IBIS)\/CSIC, Universidad de Sevilla, Sevilla, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6293-9281","authenticated-orcid":false,"given":"Laura","family":"Gallur","sequence":"additional","affiliation":[{"name":"Department of Hematology, University Hospital Vall d'Hebron, Barcelona, Spain"},{"name":"Experimental Hematology, Vall d\u2019Hebron Institute of Oncology (VHIO), Barcelona, Spain"},{"name":"Department of Medicine, Universitat Aut\u00f2noma de Barcelona, Bellaterra, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1379-0876","authenticated-orcid":false,"given":"Viktoria","family":"Blumenberg","sequence":"additional","affiliation":[{"name":"Department of Medicine III, University Hospital, LMU Munich, Munich, Germany"},{"name":"Laboratory for Translational Cancer Immunology, Gene Center of the LMU Munich, Munich, Germany"},{"name":"German Cancer Consortium (DKTK) and Bavarian Center for Cancer Research (BZKF), partner site Munich, Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5507-3985","authenticated-orcid":false,"given":"Sara","family":"Guti\u00e9rrez-Herrero","sequence":"additional","affiliation":[{"name":"Cancer Research Centre (IBMCC, USAL-CSIC), Institute for Biomedical Research of Salamanca (IBSAL) and Department of Medicine and Cytometry Service (NUCLEUS Research Support Platform), University of Salamanca (USAL), Salamanca, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4901-5858","authenticated-orcid":false,"given":"Claire","family":"Roddie","sequence":"additional","affiliation":[{"name":"Hematology Department, University College London Cancer Institute, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4015-0831","authenticated-orcid":false,"given":"Ana","family":"Benzaqu\u00e9n","sequence":"additional","affiliation":[{"name":"Haematology Department, Hospital Cl\u00ednico Universitario, Valencia, Spain"},{"name":"INCLIVA Research Institute, Valencia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Delgado-Serrano","sequence":"additional","affiliation":[{"name":"Hematology Department, Hospital Virgen del Roc\u00edo, Instituto de Biomedicina de Sevilla (IBIS)\/CSIC, Universidad de Sevilla, Sevilla, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario Andr\u00e9s","family":"S\u00e1nchez-Salinas","sequence":"additional","affiliation":[{"name":"Department of Hematology, University Hospital Vall d'Hebron, Barcelona, Spain"},{"name":"Experimental Hematology, Vall d\u2019Hebron Institute of Oncology (VHIO), Barcelona, Spain"},{"name":"Department of Medicine, Universitat Aut\u00f2noma de Barcelona, Bellaterra, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebeca","family":"Bail\u00e9n","sequence":"additional","affiliation":[{"name":"Department of Hematology, Hospital General Universitario Gregorio Mara\u00f1\u00f3n, Madrid, Spain"},{"name":"Gregorio Mara\u00f1\u00f3n Health Research Institute (IiSGM), Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia","family":"Carpio","sequence":"additional","affiliation":[{"name":"Department of Hematology, University Hospital Vall d'Hebron, Barcelona, Spain"},{"name":"Experimental Hematology, Vall d\u2019Hebron Institute of Oncology (VHIO), Barcelona, Spain"},{"name":"Department of Medicine, Universitat Aut\u00f2noma de Barcelona, Bellaterra, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"L\u00f3pez-Corral","sequence":"additional","affiliation":[{"name":"Hematology Department, Hospital Cl\u00ednico Universitario de Salamanca, IBSAL, CIBERONC, Salamanca, Spain"},{"name":"Centro de Investigaci\u00f3n del C\u00e1ncer-IBMCC, Salamanca, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1043-8076","authenticated-orcid":false,"given":"Rafael","family":"Hernani","sequence":"additional","affiliation":[{"name":"Haematology Department, Hospital Cl\u00ednico Universitario, Valencia, Spain"},{"name":"INCLIVA Research Institute, Valencia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9431-4646","authenticated-orcid":false,"given":"Mariana","family":"Bastos","sequence":"additional","affiliation":[{"name":"Department of Hematology, Hospital General Universitario Gregorio Mara\u00f1\u00f3n, Madrid, Spain"},{"name":"Gregorio Mara\u00f1\u00f3n Health Research Institute (IiSGM), Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2702-397X","authenticated-orcid":false,"given":"Maeve","family":"O'Reilly","sequence":"additional","affiliation":[{"name":"Hematology Department, University College London Cancer Institute, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7996-570X","authenticated-orcid":false,"given":"Lourdes","family":"Mart\u00edn-Mart\u00edn","sequence":"additional","affiliation":[{"name":"Cancer Research Centre (IBMCC, USAL-CSIC), Institute for Biomedical Research of Salamanca (IBSAL) and Department of Medicine and Cytometry Service (NUCLEUS Research Support Platform), University of Salamanca (USAL), Salamanca, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5708-1479","authenticated-orcid":false,"given":"Marion","family":"Subklewe","sequence":"additional","affiliation":[{"name":"Department of Medicine III, University Hospital, LMU Munich, Munich, Germany"},{"name":"Laboratory for Translational Cancer Immunology, Gene Center of the LMU Munich, Munich, Germany"},{"name":"German Cancer Consortium (DKTK) and Bavarian Center for Cancer Research (BZKF), partner site Munich, Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7076-7969","authenticated-orcid":false,"given":"Pere","family":"Barba","sequence":"additional","affiliation":[{"name":"Department of Hematology, University Hospital Vall d'Hebron, Barcelona, Spain"},{"name":"Experimental Hematology, Vall d\u2019Hebron Institute of Oncology (VHIO), Barcelona, Spain"},{"name":"Department of Medicine, Universitat Aut\u00f2noma de Barcelona, Bellaterra, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"233","reference":[{"key":"b1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-03-769620"},{"key":"b2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(18)30864-7"},{"key":"b3","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(21)00375-2"},{"key":"b4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtct.2022.05.026"},{"key":"b5","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020003092"},{"key":"b6","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.3881"},{"key":"b7","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2022.280805"},{"key":"b8","first-page":"349","volume":"140","author":"Bethge WA","year":"2022","journal-title":"Blood"},{"key":"b9","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.18209"},{"key":"b10","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-022-01969-y"},{"key":"b11","first-page":"2307","volume":"141","author":"Neelapu SS","year":"2023","journal-title":"Blood"},{"key":"b12","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2022016945"},{"key":"b13","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-022-01739-2"},{"key":"b14","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2022.281242"},{"key":"b15","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.22.01797"},{"key":"b16","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.15722"},{"key":"b17","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.76.8960"},{"key":"b18","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-014-2135-8"},{"key":"b19","doi-asserted-by":"publisher","DOI":"10.1038\/bcj.2015.86"},{"key":"b20","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.00172"},{"key":"b21","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2021005794"},{"key":"b22","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2019.08.015"},{"key":"b23","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2018.12.758"},{"key":"b24","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.54.8800"},{"key":"b25","doi-asserted-by":"publisher","DOI":"10.1002\/cyto.b.21941"},{"key":"b26","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0320(20001215)42:6<327::AID-CYTO1000>3.0.CO;2-F"},{"key":"b27","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.830773"},{"key":"b28","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020002394"},{"key":"b29","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1707447"},{"key":"b30","doi-asserted-by":"publisher","DOI":"10.1080\/00273171.2011.568786"},{"key":"b31","doi-asserted-by":"publisher","DOI":"10.1002\/sim.6607"},{"key":"b32","first-page":"1","volume":"45","author":"van Buuren S","year":"2011","journal-title":"J Stat Softw"},{"key":"b34","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-07-793760"},{"key":"b35","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2015.09.013"},{"key":"b36","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtct.2020.10.022"},{"key":"b37","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.02104"},{"key":"b38","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-004475"},{"key":"b39","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)61763-2"},{"key":"b40","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.18.00605"},{"key":"b41","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(16)30097-3"},{"key":"b42","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)31366-0"},{"key":"b43","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13236073"},{"key":"b44","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.02103"},{"key":"b45","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-11-883710"},{"key":"b46","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.21.02370"},{"key":"b47","doi-asserted-by":"publisher","DOI":"10.1002\/hon.2797"},{"key":"b48","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020010543"}],"container-title":["Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ascopubs.org\/doi\/pdfdirect\/10.1200\/JCO.23.01097","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,5]],"date-time":"2024-01-05T18:01:33Z","timestamp":1704477693000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascopubs.org\/doi\/10.1200\/JCO.23.01097"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,10]]},"references-count":47,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,1,10]]}},"alternative-id":["10.1200\/JCO.23.01097"],"URL":"https:\/\/doi.org\/10.1200\/jco.23.01097","relation":{},"ISSN":["0732-183X","1527-7755"],"issn-type":[{"value":"0732-183X","type":"print"},{"value":"1527-7755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,10]]},"assertion":[{"value":"2023-05-23","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-08-10","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-08-21","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-10-24","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}